Developing talent – Chinese education and the pharmaceutical sciences

Richard Tadd Blog

There’s a revolution taking place in China’s healthcare sector, and it has nothing to do with COVID-19. Despite all the reports you may have seen suggesting that new medical infrastructure in the country was being developed in response to the emergence of the new coronavirus, this is something that was in motion long before, and it’s set to change millions …

Healthcare research – understanding the Chinese regulatory framework

Richard Tadd Blog

China has always been an attractive destination for researchers in the healthcare sector because of its size and population, and the scale of studies thus made possible. Until recently, though, its regulatory system was cumbersome and not well designed for foreigners, who found it hard to understand what was required of them. Thankfully, the past couple of years have seen …

The developing biotech sector in China

Richard Tadd Blog

Twenty years ago, China’s biotech industry was worth around $2.4bn. This year, its revenues are expected to exceed $1.2tn. That’s a remarkable achievement by any standards, and one that has understandably led to excitement among investors and industry professionals alike. How has it been achieved? How has the sector actually changed and what can we expect to see in the …

Tackling the 2019-nCoV coronavirus – what the experts are doing

Richard Tadd Blog

The emergence of a new, potentially dangerous coronavirus in the city of Wuhan in China’s Hubei province has sparked a flurry of articles in the international media and widespread discussion on social media, much of it poorly informed or coloured by politics. With epidemiologists from multiple nations working together to tackle the outbreak, cooperation and the clear exchange of information …